ArticleBlood2019
Open access · bronzeAbstract read
In one paragraph
Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.
- Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.Blood advances · 2020Pooled it
- Stage-Specific Degradation of Cyclin D3 Orchestrates Myelopoiesis and Restrains Myeloproliferative Neoplasm Development.Cancer research · 2026Article
- Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non-Hodgkin lymphomas.British journal of haematology · 2026Article
- Blastoid Mantle Cell Lymphoma in the Leukemic Phase: Resolving a Morphological Dilemma Through Flow Cytometry.Cureus · 2026Article
- Efficacy and safety analysis of a novel BTK inhibitor in patients with mantle cell lymphoma harboring TP53 mutations.American journal of cancer research · 2026Article
- Article
- Article
- Composite chronic lymphocytic leukemia and mantle cell lymphoma involving the bone marrow: a case report and literature review.Journal of pathology and translational medicine · 2025Article
- Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.Blood advances · 2024Article
- Cyclin D1-negative and SOX11-positive B-cell lymphoma with CD5 and CD10 coexpression andEJHaem · 2024Article
- Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.Haematologica · 2024Article
- Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma.Blood advances · 2024Review
- Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.Annals of hematology · 2024Article
- Diagnostic and prognostic molecular pathology of lymphoid malignancies.Virchows Archiv : an international journal of pathology · 2024Review
- Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.Virchows Archiv : an international journal of pathology · 2024Review
- Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.Frontiers of medicine · 2023Article
- Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.Virchows Archiv : an international journal of pathology · 2023Review
- Case report: Identification of atypical mantle cell lymphoma withFrontiers in oncology · 2023Article
- Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.Journal of the Egyptian National Cancer Institute · 2022Review
- Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.JCO precision oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors at 20 institutions in 9 countries.
David Martín-GarciaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0002-0289-5915
Alba NavarroInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Rafael Valdés-MasDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
Guillem ClotInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0003-2588-7413
Jesús Gutiérrez-AbrilDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
Miriam PrietoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Inmaculada Ribera-CortadaHospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra.
Renata WoronieckaCytogenetic Laboratory and.
Grzegorz RymkiewiczDepartment of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
Susanne BensInstitute of Human Genetics, Ulm University Medical Center, Ulm University, Ulm, Germany.
Laurence de LevalInstitut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0003-3994-516X
Andreas RosenwaldInstitute of Pathology and.
Judith A FerryDepartment of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Eric D HsiCleveland Clinic Foundation, Cleveland, OH.
Kai FuDepartment of Pathology and Microbiology and.
Jan DelabieDepartment of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-5023-0689
Dennis WeisenburgerDepartment of Pathology, City of Hope National Medical Center, Duarte, CA.
Daphne de JongVU University Medical Center, Amsterdam, The Netherlands.
Fina ClimentHospital Universitari de Bellvitge-Institut d'Investigació Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Sheila J O'ConnorHaematological Malignancy Diagnostic Service (HMDS) Laboratory, St. James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Steven H SwerdlowDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
David TorrentsJoint Barcelona Supercomputing Center (BSC)-Centre for Genomic Regulation (CRG)-Institute for Research in Biomedicine (IRB) Research Programme in Computational Biology, Barcelona, Spain.ORCID 0000-0002-6086-9037
Sergi BeltranCentre Nacional d'Anàlisi Genòmica (CNAG)-CRG, Barcelona, Spain.ORCID 0000-0002-2810-3445
Blanca EspinetLaboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
Blanca González-FarréCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Luis VelozaHematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.
Dolors CostaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Estella MatutesHematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.
Reiner SiebertInstitute of Human Genetics, Ulm University Medical Center, Ulm University, Ulm, Germany.
German OttDepartment of Clinical Pathology and.
Leticia Quintanilla-MartinezInstitute of Pathology, Eberhard Karls University of Tübingen, Tübingen, Germany.ORCID 0000-0001-7156-5365
Elaine S JaffeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.ORCID 0000-0003-4632-0301
Carlos López-OtínCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Itziar SalaverriaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0002-2427-9822
Xose S PuenteCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.ORCID 0000-0001-9525-1483
Elias CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0001-9850-9793
Sílvia BeàInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0001-7192-2385
Centro de Investigación Biomédica en Red de Cáncer · ESHospital Clínic de Barcelona · ESUniversidad de Oviedo · ESUniversität Ulm · DEAmsterdam UMC Location Vrije Universiteit Amsterdam · NLBellvitge University Hospital · ESCentro Nacional de Análisis Genómico · ESCity Of Hope National Medical Center · USCleveland Clinic · USHarvard University · USHospital Del Mar · ESInstitució Catalana de Recerca i Estudis Avançats · ESLeeds Teaching Hospitals NHS Trust · GBNational Institutes of Health · USOslo University Hospital · NORobert Bosch Hospital · DEThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity Hospital of Lausanne · CHUniversity of Nebraska Medical Center · USUniversity of Pittsburgh · US
Funding
Hematopathology DiagnosisZIABC011070 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$14.5MAbstract
Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation resulting in overexpression of cyclin D1. However, a small subset of cyclin D1
Indexed as
Enhancer Elements, GeneticGene RearrangementAgedCyclin D1Cyclin D2Cyclin D3FemaleHumansImmunoglobulin Light ChainsLymphoma, Mantle-CellMaleMiddle AgedPrognosisSOXC Transcription FactorsTranslocation, GeneticCCND1 protein, humanCCND2 protein, humanCCND3 protein, humanCyclin D1Cyclin D2Cyclin D3Immunoglobulin Light ChainsSOX11 protein, humanSOXC Transcription Factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.